1-(thiophen-2-ylmethyl)-N-(3,3,3-trifluoro-2-piperazin-1-ylpropyl)triazole-4-carboxamide;hydrochloride
C15H20ClF3N6OS — CID 120813198
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(thiophen-2-ylmethyl)-N-(3,3,3-trifluoro-2-piperazin-1-ylpropyl)triazole-4-carboxamide;hydrochloride
1-(thiophen-2-ylmethyl)-N-(3,3,3-trifluoro-2-piperazin-1-ylpropyl)triazole-4-carboxamide;hydrochloride (PubChem CID 120813198) has the molecular formula C15H20ClF3N6OS and a molecular weight of 424.88 g/mol. Its IUPAC name is 1-(thiophen-2-ylmethyl)-N-(3,3,3-trifluoro-2-piperazin-1-ylpropyl)triazole-4-carboxamide;hydrochloride.
Molecular Properties
| Compound Name | 1-(thiophen-2-ylmethyl)-N-(3,3,3-trifluoro-2-piperazin-1-ylpropyl)triazole-4-carboxamide;hydrochloride |
|---|---|
| PubChem CID | 120813198 |
| Molecular Formula | C15H20ClF3N6OS |
| Molecular Weight | 424.88 g/mol |
| Exact Mass | 424.11 |
| IUPAC Name | 1-(thiophen-2-ylmethyl)-N-(3,3,3-trifluoro-2-piperazin-1-ylpropyl)triazole-4-carboxamide;hydrochloride |
| SMILES | Cl.O=C(NCC(N1CCNCC1)C(F)(F)F)c1cn(Cc2cccs2)nn1 |
| InChI | InChI=1S/C15H19F3N6OS.ClH/c16-15(17,18)13(23-5-3-19-4-6-23)8-20-14(25)12-10-24(22-21-12)9-11-2-1-7-26-11;/h1-2,7,10,13,19H,3-6,8-9H2,(H,20,25);1H |
| InChIKey | XHYSBOKTIUCIGV-UHFFFAOYSA-N |
| XLogP | 1.38 |
| TPSA | 75.08 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 424.88 |
| LogP ≤ 5 | 1.38 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 120813198 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.